Clovis Oncology Announces Exercise by Initial Purchasers of Their Option to Purchase an Additional $13.0 Million Aggregate Principal Amount of the Company’s 4.50% Convertible Senior Notes Due 2024

BOULDER, Colo.–(BUSINESS WIRE)–$CLVS–Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that the initial purchasers of the previously announced offering of the Company’s 4.50% Convertible Senior Notes due 2024 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, have elected to exercise their option … [Read more…]

Fuse Medical Announces Launch of Sterizo Total Knee Replacement System

RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc., (OTCPK: FZMD), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the launch of the Sterizo Total Knee Replacement System, the latest addition to a comprehensive line of orthopedic product offerings. The Sterizo Total Knee System is a next generation technology platform based … [Read more…]

Aptar Announces Capital Markets Day and Confirms Third Quarter Conference Call Date

CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in dispensing, drug delivery and active packaging solutions, announced today that the company will host its Capital Markets Day in New York City, on Thursday, September 5, 2019. The event will begin at 8:00 a.m. EDT. Senior executives from the company will speak and then … [Read more…]

Anthem Announces Appearance at Upcoming Conference

INDIANAPOLIS–(BUSINESS WIRE)–Anthem, Inc. (NYSE: ANTM) announced today that senior management is scheduled to present at the 2019 Wells Fargo Healthcare Conference on September 5, 2019, at 9:10 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a webcast of the presentation by visiting and selecting the “Investors” link. Following the … [Read more…]

bluebird bio Announces Investor Events in September

CAMBRIDGE, Mass.–(BUSINESS WIRE)–bluebird bio, Inc. (Nasdaq: BLUE) today announced that members of the management team will present at the following upcoming investor conferences in September: Citi 14th Annual Biotech Conference, Wednesday, September 4, at 8:00 a.m. ET at the Four Seasons Boston, Boston, MA Morgan Stanley 17th Annual Global Healthcare Conference, Wednesday, September 11, at … [Read more…]

Lantheus Holdings to Present at the Wells Fargo Securities 2019 Healthcare Conference

NORTH BILLERICA, Mass.–(BUSINESS WIRE)–Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced it will be presenting at the Wells Fargo Securities 2019 Healthcare Conference on Thursday, September 5 at the … [Read more…]

Apple Health Records Available for Allscripts Clients

Allscripts offers new way to access Allscripts iPhone users’ health data CHICAGO–(BUSINESS WIRE)–#healthIT–Today, Allscripts (NASDAQ: MDRX) announced that Apple Health Records is now available for Allscripts Sunrise™, TouchWorks® and Professional EHR™ clients and their patients. Health Records brings together hospitals, clinics and the existing Apple Health app to make it easy for individuals to see … [Read more…]

Investigation Report on China’s Recombinant Follitropin Beta Market, 2013-2018 & 2019-2023 –

DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Recombinant Follitropin Beta Market, 2019-2023” report has been added to’s offering. In China, the number of infertile couples is increasing. According to Chinese media, in 2018, more than 40 million people in China were infertile, with the incidence of infertility in couples of childbearing age increasing from 3% … [Read more…]

Global Janus Kinase (JAK) Inhibitors Market Report 2019-2023 with Market Positioning of Key Vendors –

DUBLIN–(BUSINESS WIRE)–The “Global Janus Kinase (JAK) Inhibitors Market 2019-2023” report has been added to’s offering. Global janus kinase (JAK) inhibitors are drugs that inhibit the abnormal functionality of enzymes in the JAK family such as JAK1, JAK2, JAK3, and TYK2. The inhibition of these enzymes helps interfere with the JAK-STAT signaling pathway, which has … [Read more…]

Imbrium Therapeutics L.P. and SpineThera Announce Issuance of U.S. Patent Covering Composition of Matter Protection for SX600, a Non-Opioid Product in Development for Epidural Steroid Injection for the Treatment of Low Back Pain

SpineThera’s clinical development program for SX600 will evaluate sustained-release, injectable treatment options for pain in and near the spine STAMFORD, Conn.–(BUSINESS WIRE)–Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma L.P., in conjunction with SpineThera, Inc., today announced issuance of U.S. Patent No. 10,350,222 from the United States Patent and Trademark … [Read more…]